Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging insights into transcriptional condensates. | Exp Mol Med | 2024 | 38658705 | PubTator, text mining | PubMed |
| GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases. | Mod Pathol | 2024 | 38621503 | PubTator, text mining | PubMed |
| Tumor-associated macrophage-derived exosomal miR21-5p promotes tumor angiogenesis by regulating YAP1/HIF-1α axis in head and neck squamous cell carcinoma. | Cell Mol Life Sci | 2024 | 38602536 | PubTator, text mining | PubMed |
| LATS1 controls CTCF chromatin occupancy and hormonal response of 3D-grown breast cancer cells. | EMBO J | 2024 | 38565950 | PubTator, text mining | PubMed |
| AI is a viable alternative to high throughput screening: a 318-target study. | Sci Rep | 2024 | 38565852 | PubTator, text mining | PubMed |
| Ischemia-inhibited ferric chelate reductase 1 improves ferroptosis-mediated intestinal ischemia injury via Hippo signaling. | Int Immunopharmacol | 2024 | 38531200 | PubTator, text mining | PubMed |
| HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14. | bioRxiv | 2024 | 38496413 | PubTator, text mining | PubMed |
| Survival-Associated Cellular Response Maintained in Pancreatic Ductal Adenocarcinoma (PDAC) Switched Between Soft and Stiff 3D Microgel Culture. | ACS Biomater Sci Eng | 2024 | 38466617 | PubTator, text mining | PubMed |
| The significance of Hippo pathway protein expression in oral squamous cell carcinoma. | Front Med (Lausanne) | 2024 | 38444414 | PubTator, text mining | PubMed |
| The ability of the LIMD1 and TRIP6 LIM domains to bind strained f-actin is critical for their tension dependent localization to adherens junctions and association with the Hippo pathway kinase LATS1. | Cytoskeleton (Hoboken) | 2024 | 38426816 | PubTator, text mining | PubMed |
| m6A-induced TRIB3 regulates Hippo pathway through interacting with LATS1 to promote the progression of lung adenocarcinoma. | J Cell Physiol | 2024 | 38372068 | PubTator, text mining | PubMed |
| (S)-10-Hydroxycamptothecin Inhibits EMT-evoked Osteosarcoma Cell Growth and Metastasis by Activating the HIPPO Signaling Pathway. | Comb Chem High Throughput Screen | 2024 | 38369725 | PubTator, text mining | PubMed |
| Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib. | Sci Rep | 2024 | 38368446 | PubTator, text mining | PubMed |
| Identification of EMT-associated prognostic features among grade II/III gliomas. | Sci Rep | 2024 | 38307919 | PubTator, text mining | PubMed |
| Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma. | Nat Commun | 2024 | 38302473 | PubTator, text mining | PubMed |
| FERM domain-containing proteins are active components of the cell nucleus. | Life Sci Alliance | 2024 | 38296350 | PubTator, text mining | PubMed |
| The m6A methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894. | Cancer Cell Int | 2024 | 38291427 | PubTator, text mining | PubMed |
| Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications. | Onco Targets Ther | 2024 | 38283733 | PubTator, text mining | PubMed |
| LATS1 Promotes B-ALL Tumorigenesis by Regulating YAP1 Phosphorylation and Subcellular Localization. | Curr Med Sci | 2024 | 38277019 | PubTator, text mining | PubMed |
| UBDP1 pseudogene and UBD network competitively bind miR‑6072 to promote glioma progression. | Int J Oncol | 2024 | 38275102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=10